LifeMD, AT&T Partner to Expand Virtual Care Access
TipRanks (Tue, 15-Sep 10:48 AM ET)
AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD
PRNewswire (Tue, 15-Sep 9:01 AM ET)
UPDATE - LifeMD Reports Second Quarter 2026 Results
Globe Newswire (Wed, 5-Aug 7:45 PM ET)
LifeMD Reports Second Quarter 2026 Results
Globe Newswire (Wed, 5-Aug 4:11 PM ET)
LifeMD to Report Second Quarter 2026 Financial Results on August 5
Globe Newswire (Fri, 24-Jul 4:05 PM ET)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Globe Newswire (Tue, 23-Jun 8:00 AM ET)
Globe Newswire (Mon, 22-Jun 8:00 AM ET)
LifeMD Builds AI-Focused Leadership Team, Appoints New CFO With Deep Healthcare Finance Experience
Market Chameleon (Mon, 16-Mar 7:44 AM ET)
LifeMD Appoints Dr. Tara Scott as Ambassador to Bolster Comprehensive Women’s Health Program
Market Chameleon (Wed, 22-Oct 5:36 AM ET)
LifeMD Broadens Access to Ozempic for $499 Per Month Through Direct Collaboration with Novo Nordisk
Market Chameleon (Tue, 30-Sep 4:46 AM ET)
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Lifemd trades on the NASDAQ stock market under the symbol LFMD.
As of September 15, 2026, LFMD stock price declined to $3.40 with 977,832 million shares trading.
LFMD has a beta of 1.44, meaning it tends to be more sensitive to market movements. LFMD has a correlation of 0.07 to the broad based SPY ETF.
LFMD has a market cap of $163.88 million. This is considered a Micro Cap stock.
Last quarter Lifemd reported $47 million in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.08.
In the last 3 years, LFMD traded as high as $15.84 and as low as $2.56.
The top ETF exchange traded funds that LFMD belongs to (by Net Assets): VTI, IWM, KOMP, VXF, IWO.
LFMD has underperformed the market in the last year with a return of -41.4%, while the SPY ETF gained +16.4%. In the last 3 month period, LFMD fell short of the market, returning -27.7%, while SPY returned +2.4%. However, in the most recent 2 weeks LFMD has outperformed the stock market by returning +10.0%, while SPY returned -1.3%.
LFMD support price is $3.31 and resistance is $3.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMD shares will trade within this expected range on the day.